Comerica Bank Buys 13,666 Shares of ICU Medical, Inc. $ICUI

Comerica Bank raised its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 52.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 39,658 shares of the medical instruments supplier’s stock after buying an additional 13,666 shares during the period. Comerica Bank’s holdings in ICU Medical were worth $5,658,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in ICUI. Millennium Management LLC increased its holdings in shares of ICU Medical by 173.4% in the 3rd quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after buying an additional 690,694 shares during the last quarter. UBS Group AG increased its holdings in shares of ICU Medical by 239.8% in the 3rd quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock worth $46,371,000 after buying an additional 272,782 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of ICU Medical by 34.0% in the 3rd quarter. Ameriprise Financial Inc. now owns 803,542 shares of the medical instruments supplier’s stock worth $96,393,000 after buying an additional 203,746 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of ICU Medical by 25.2% in the 3rd quarter. Schroder Investment Management Group now owns 796,704 shares of the medical instruments supplier’s stock worth $93,246,000 after buying an additional 160,380 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of ICU Medical by 16.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 872,993 shares of the medical instruments supplier’s stock worth $104,718,000 after buying an additional 126,072 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

Analysts Set New Price Targets

ICUI has been the topic of several recent research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a report on Thursday, January 22nd. KeyCorp reduced their target price on shares of ICU Medical from $180.00 to $164.00 and set an “overweight” rating on the stock in a report on Monday. Piper Sandler reduced their target price on shares of ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Finally, Wall Street Zen lowered shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday, April 18th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $169.00.

ICU Medical Price Performance

ICUI stock opened at $119.20 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.15 and a current ratio of 2.39. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $160.29. The firm’s fifty day moving average is $130.96 and its 200 day moving average is $137.99. The firm has a market cap of $2.98 billion, a P/E ratio of 5,962.98, a P/E/G ratio of 1.66 and a beta of 0.85.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 EPS for the quarter, beating the consensus estimate of $1.68 by $0.23. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. The company had revenue of $535.94 million for the quarter, compared to analyst estimates of $541.20 million. During the same quarter last year, the firm earned $2.11 EPS. The firm’s quarterly revenue was down 14.1% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Research analysts predict that ICU Medical, Inc. will post 6.31 earnings per share for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.